Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS

Impact · against what's priced in

The reduction in the 2027 Star Rating for Alignment's primary California HMO contract is a significant negative for 2027 EPS, though the market has already begun aggressively repricing the stock. The 13% single-day drop to a 52-week low indicates the immediate financial impact of the bonus loss is being rapidly absorbed by the current share price.

ALHC−0.70

No priced-in read yet